A study in Nature Communications reports dynamics of age-related divergence of circulating immune responses in patients with solid tumors treated with immune checkpoint inhibitors. go.nature.com/3GlO49I #immunosky #medsky 🧪

New study led by @danielzabransky.bsky.social lab Older adults respond well to anti-PD1 therapy, despite age-related immune changes 🔗 nature.com/articles/s41... Findings unlikely to extend to other forms of immunotherapy (eg cancer vaccines, etc.) which rely on naive T cells